209 related articles for article (PubMed ID: 17044661)
21. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
Masumiya H; Shijuku T; Tanaka H; Shigenobu K
Eur J Pharmacol; 1998 May; 349(2-3):351-7. PubMed ID: 9671117
[TBL] [Abstract][Full Text] [Related]
22. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
Tanaka H; Komikado C; Shimada H; Takeda K; Namekata I; Kawanishi T; Shigenobu K
J Pharmacol Sci; 2004 Dec; 96(4):499-501. PubMed ID: 15599089
[TBL] [Abstract][Full Text] [Related]
23. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
[TBL] [Abstract][Full Text] [Related]
24. Efonidipine, a Ca(2+)-channel blocker, enhances the production of dehydroepiandrosterone sulfate in NCI-H295R human adrenocortical carcinoma cells.
Ikeda K; Saito T; Tojo K
Tohoku J Exp Med; 2011 Aug; 224(4):263-71. PubMed ID: 21757861
[TBL] [Abstract][Full Text] [Related]
25. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans.
Held K; Antonijevic IA; Künzel H; Uhr M; Wetter TC; Golly IC; Steiger A; Murck H
Pharmacopsychiatry; 2002 Jul; 35(4):135-43. PubMed ID: 12163983
[TBL] [Abstract][Full Text] [Related]
26. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
27. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers.
Troughton RW; Frampton CM; Lewis LK; Yandle TG; Richards AM; Nicholls MG
Clin Sci (Lond); 2001 Jul; 101(1):103-9. PubMed ID: 11410122
[TBL] [Abstract][Full Text] [Related]
28. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
[TBL] [Abstract][Full Text] [Related]
29. Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
Life Sci; 2000 Dec; 68(3):345-51. PubMed ID: 11191650
[TBL] [Abstract][Full Text] [Related]
30. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
31. Role of specific T-type calcium channel blocker R(-) efonidipine in the regulation of renal medullary circulation.
Hu C; Mori T; Lu Y; Guo Q; Sun Y; Yoneki Y; Ohsaki Y; Nakamichi T; Oba I; Sato E; Ogawa S; Dickinson BC; Chang CJ; Miyata T; Sato H; Ito S
J Hypertens; 2012 Aug; 30(8):1620-31. PubMed ID: 22688264
[TBL] [Abstract][Full Text] [Related]
32. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
33. Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
Ragueneau I; Sao AB; Démolis JL; Darné B; Funck-Brentano C; Jaillon P
Clin Pharmacol Ther; 2001 Mar; 69(3):122-9. PubMed ID: 11240976
[TBL] [Abstract][Full Text] [Related]
34. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
[TBL] [Abstract][Full Text] [Related]
35. Plasma aldosterone, angiotensin II, and arginine vasotocin concentrations in the toad, Bufo marinus, following osmotic treatments.
Konno N; Hyodo S; Takei Y; Matsuda K; Uchiyama M
Gen Comp Endocrinol; 2005 Jan; 140(2):86-93. PubMed ID: 15613270
[TBL] [Abstract][Full Text] [Related]
36. Role of voltage-gated calcium channels in potassium-stimulated aldosterone secretion from rat adrenal zona glomerulosa cells.
Uebele VN; Nuss CE; Renger JJ; Connolly TM
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):209-18. PubMed ID: 15555914
[TBL] [Abstract][Full Text] [Related]
37. Time course of regression of vascular structural changes and its relation to cytosolic free calcium in hypertensives after nilvadipine treatment.
Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Inoue H
J Hum Hypertens; 1995 Sep; 9(9):735-9. PubMed ID: 8551487
[TBL] [Abstract][Full Text] [Related]
38. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
39. Effect of nifedipine on blood pressure and adrenocortical responses to trophic stimuli in humans.
Millar JA; Struthers AD; Beastall GH; Reid JL
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S330-4. PubMed ID: 6184563
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamic and endocrine effects of digitoxin in healthy volunteers.
Lucena MI; Moreno A; Garcia del Rio C; Bolaños MJ; Andrade R
Int J Clin Pharmacol Res; 1987; 7(2):135-40. PubMed ID: 3294618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
